Prytime Medical Announces the Launch of the PROMPT Observational Clinical Trial, the first prospective in-human study of Partial REBOA
San Antonio, TX (PRWEB) March 16, 2023 -- Prytime Medical Inc, The REBOA Company™, the leading innovator and global provider of lifesaving REBOA products for
Source: prweb.com